EVOEvotec SE
$1.52-62% 1Y
$1.52
$1.3452 weeks$4.15
The financials
Evotec SE by the numbers
For the full year FY2025, revenue was €788M (−1.1% year on year) and net income −€104M.
Drug Manufacturers, Specialty & Generic
Ranks #23 of 39 by RyuScore
For the full year FY2025, revenue was €788M (−1.1% year on year) and net income −€104M.
Ranks #23 of 39 by RyuScore